Table 6.
Exposure group | Comparison group | |||
Pre-action | Post-action | Pre-action | Post-action | |
Beta blocking agents | ||||
The number of days of drugs | ||||
25% | 60 | 120 | 56 | 120 |
50% | 92 | 180 | 90 | 170 |
75% | 140 | 210 | 140 | 210 |
95% | 168 | 224 | 168 | 228 |
99% | 180 | 252 | 196 | 249 |
100% | 210 | 280 | 224 | 300 |
The number of visits | ||||
25% | 2 | 4 | 2 | 4 |
50% | 4 | 7 | 4 | 6 |
75% | 5 | 7 | 5 | 7 |
95% | 6 | 8 | 6 | 8 |
99% | 10 | 11 | 8 | 10 |
100% | 13 | 14 | 23 | 24 |
The number drug items | ||||
25% | 1 | 1 | 1 | 1 |
50% | 1 | 1 | 1 | 1 |
75% | 1 | 1 | 1 | 1 |
95% | 1 | 2 | 1 | 2 |
99% | 2 | 2 | 2 | 3 |
100% | 3 | 3 | 2 | 4 |
Calcium channel blockers, vascular effects | ||||
The number of days of drugs | ||||
25% | 60 | 120 | 56 | 120 |
50% | 112 | 180 | 90 | 180 |
75% | 140 | 210 | 133 | 198 |
95% | 168 | 224 | 168 | 225 |
99% | 180 | 264 | 182 | 240 |
100% | 196 | 330 | 224 | 300 |
The number of visits | ||||
25% | 3 | 5 | 2 | 4 |
50% | 4 | 6 | 3 | 6 |
75% | 5 | 7 | 5 | 7 |
95% | 6 | 8 | 6 | 8 |
99% | 12 | 13 | 9 | 11 |
100% | 30 | 27 | 12 | 13 |
The number drug items | ||||
25% | 1 | 1 | 1 | 1 |
50% | 1 | 1 | 1 | 1 |
75% | 1 | 1 | 1 | 1 |
95% | 2 | 2 | 1 | 1 |
99% | 2 | 2 | 1 | 2 |
100% | 4 | 3 | 2 | 3 |
ACE inhibitors, plain | ||||
The number of days of drugs | ||||
25% | 60 | 112 | 60 | 112 |
50% | 112 | 168 | 104 | 168 |
75% | 140 | 202 | 140 | 203 |
95% | 168 | 224 | 172 | 224 |
99% | 180 | 249 | 196 | 240 |
100% | 224 | 288 | 240 | 245 |
The number of visits | ||||
25% | 2 | 4 | 2 | 4 |
50% | 4 | 6 | 4 | 6 |
75% | 5 | 7 | 5 | 7 |
95% | 7 | 9 | 7 | 9 |
99% | 12 | 14 | 12 | 13 |
100% | 30 | 27 | 12 | 14 |
The number drug items | ||||
25% | 1 | 1 | 1 | 1 |
50% | 1 | 1 | 1 | 1 |
75% | 1 | 1 | 1 | 1 |
95% | 1 | 2 | 1 | 1 |
99% | 2 | 3 | 2 | 2 |
100% | 3 | 3 | 2 | 2 |